The Interaction between Factor H and Von Willebrand Factor

• Shuju Feng,

  Affiliation Division of Internal Medicine, Benign Hematology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Xiaowen Liang,

  Affiliation Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, Texas, United States of America

  ⨯
• Miguel A. Cruz,

  Affiliation Cardiovascular Research Section, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Hangoc Vu,

  Affiliation Division of Internal Medicine, Benign Hematology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Zhou Zhou,

  Affiliation Puget Sound Blood Center, Seattle, Washington, United States of America

  ⨯
• Naresh Pemmaraju,

  Affiliation Division of Internal Medicine, Benign Hematology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Jing-Fei Dong,

  Affiliation Puget Sound Blood Center, Seattle, Washington, United States of America

  ⨯
• Michael H. Kroll,

  Affiliation Division of Internal Medicine, Benign Hematology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Vahid Afshar-Kharghan

  * E-mail: vakharghan@mdanderson.org

  Affiliation Division of Internal Medicine, Benign Hematology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯